EDGAR Filing Documents for 0001213900-23-089284

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001213900-23-089284

Filing Date

2023-11-21

Accepted

2023-11-21 16:41:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ea188706-s3_tffpharma.htm	S-3	497813
2	FORM OF SENIOR INDENTURE	ea188706ex4-2_tffpharma.htm	EX-4.2	421569
3	FORM OF SUBORDINATED INDENTURE	ea188706ex4-3_tffpharma.htm	EX-4.3	354210
4	FORM OF SENIOR NOTE	ea188706ex4-4_tffpharma.htm	EX-4.4	53937
5	FORM OF SUBORDINATED NOTE	ea188706ex4-5_tffpharma.htm	EX-4.5	48808
6	OPINION AND CONSENT OF GREENBERG TRAURIG, LLP	ea188706ex5-1_tffpharma.htm	EX-5.1	18734
7	CONSENT OF MARCUM LLP	ea188706ex23-1_tffpharma.htm	EX-23.1	2371
8	FILING FEE TABLE	ea188706ex-fee_tffpharma.htm	EX-FILING FEES	123005
9	GRAPHIC	img_001.jpg	GRAPHIC	9470
	Complete submission text file	0001213900-23-089284.txt		1534573

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746

Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973

TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)